HIGHLIGHTS
- who: Maxim Moreau and collaborators from the (UNIVERSITY) have published the paper: Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model, in the Journal: (JOURNAL)
- what: The aim of this prospective, randomized, controlled, double-blind study was to evaluate the effects of tiludronate (TLN), a bisphosphonate, on structural, biochemical and molecular changes and function in an experimental dog model of osteoarthritis (OA). The authors hypothesized that the bone anti-resorptive action of TLN might curb the development of structural and functional joint lesions associated with ACL transection. This . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.